KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Gains from Sales and Divestitures (2016 - 2025)

Stereotaxis (STXS) has disclosed Gains from Sales and Divestitures for 14 consecutive years, with $240000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 63.22% to $240000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $240000.0, a 63.22% decrease, with the full-year FY2024 number at $652544.0, changed N/A from a year prior.
  • Gains from Sales and Divestitures was $240000.0 for Q3 2025 at Stereotaxis, up from $120000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $652544.0 in Q3 2024 to a low of $10699.0 in Q1 2022.
  • A 5-year average of $234996.3 and a median of $147027.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 96.07% in 2022, then surged 1246.42% in 2023.
  • Stereotaxis' Gains from Sales and Divestitures stood at $325954.0 in 2021, then tumbled by 66.03% to $110726.0 in 2022, then skyrocketed by 185.97% to $316646.0 in 2023, then soared by 106.08% to $652544.0 in 2024, then crashed by 63.22% to $240000.0 in 2025.
  • Per Business Quant, the three most recent readings for STXS's Gains from Sales and Divestitures are $240000.0 (Q3 2025), $120000.0 (Q2 2025), and $120000.0 (Q1 2025).